<!DOCTYPE html>
<html lang="en-us">

<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="generator" content="Source Themes Academic 4.5.0">

  

  
  
  
  
  
    
    
    
  
  

  <meta name="author" content="Sam Robson">

  
  
  
    
  
  <meta name="description" content="Recent evidence suggests that inhibition of bromodomain and extra-terminal (BET) epigenetic readers may have clinical utility against acute myeloid leukemia (AML). Here we validate this hypothesis, demonstrating the efficacy of the BET inhibitor I-BET151 across a variety of AML subtypes driven by disparate mutations. We demonstrate that a common ‘core’ transcriptional program, which is HOX gene independent, is downregulated in AML and underlies sensitivity to I-BET treatment. This program is enriched for genes that contain ‘super-enhancers’, recently described regulatory elements postulated to control key oncogenic driver genes. Moreover, our program can independently classify AML patients into distinct cytogenetic and molecular subgroups, suggesting that it contains biomarkers of sensitivity and response. We focus AML with mutations of the Nucleophosmin gene (NPM1) and show evidence to suggest that wild-type NPM1 has an inhibitory influence on BRD4 that is relieved upon NPM1c mutation and cytosplasmic dislocation. This leads to the upregulation of the core transcriptional program facilitating leukemia development. This program is abrogated by I-BET therapy and by nuclear restoration of NPM1. Finally, we demonstrate the efficacy of I-BET151 in a unique murine model and in primary patient samples of NPM1c AML. Taken together, our data support the use of BET inhibitors in clinical trials in AML.">

  
  <link rel="alternate" hreflang="en-us" href="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/">

  


  
  
  
  <meta name="theme-color" content="#2962ff">
  

  
  
  
  
    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/academicons/1.8.6/css/academicons.min.css" integrity="sha256-uFVgMKfistnJAfoCUQigIl+JfUaP47GrRKjf6CTPVmw=" crossorigin="anonymous">
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.6.0/css/all.css" integrity="sha384-aOkxzJ5uQz7WBObEZcHvV5JvRW3TUc2rNPA7pe3AwnsUohiw1Vj2Rgx2KSOkF5+h" crossorigin="anonymous">
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.css" integrity="sha256-ygkqlh3CYSUri3LhQxzdcm0n1EQvH2Y+U5S2idbLtxs=" crossorigin="anonymous">

    
    
    
      
    
    
      
      
        
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/github.min.css" crossorigin="anonymous" title="hl-light">
          <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/styles/dracula.min.css" crossorigin="anonymous" title="hl-dark" disabled>
        
      
    

    
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.css" integrity="sha512-M2wvCLH6DSRazYeZRIm1JnYyh22purTM+FDB5CsyxtQJYeKq83arPe5wgbNmcFXGqiSH2XR8dT/fJISVA1r/zQ==" crossorigin="anonymous">
    

    

  

  
  
  
  <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Montserrat:400,700%7CRoboto:400,400italic,700%7CRoboto+Mono&display=swap">
  

  
  
  
  <link rel="stylesheet" href="/css/academic.min.1884ccbe79662c38d99b291260b58a24.css">

  

  




  


  

  <link rel="manifest" href="/index.webmanifest">
  <link rel="icon" type="image/png" href="/img/icon-32.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/icon-192.png">

  <link rel="canonical" href="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/">

  
  
  
  
    
  
  
  <meta property="twitter:card" content="summary_large_image">
  
  <meta property="og:site_name" content="IRunFasterThanMyCode">
  <meta property="og:url" content="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/">
  <meta property="og:title" content="Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia | IRunFasterThanMyCode">
  <meta property="og:description" content="Recent evidence suggests that inhibition of bromodomain and extra-terminal (BET) epigenetic readers may have clinical utility against acute myeloid leukemia (AML). Here we validate this hypothesis, demonstrating the efficacy of the BET inhibitor I-BET151 across a variety of AML subtypes driven by disparate mutations. We demonstrate that a common ‘core’ transcriptional program, which is HOX gene independent, is downregulated in AML and underlies sensitivity to I-BET treatment. This program is enriched for genes that contain ‘super-enhancers’, recently described regulatory elements postulated to control key oncogenic driver genes. Moreover, our program can independently classify AML patients into distinct cytogenetic and molecular subgroups, suggesting that it contains biomarkers of sensitivity and response. We focus AML with mutations of the Nucleophosmin gene (NPM1) and show evidence to suggest that wild-type NPM1 has an inhibitory influence on BRD4 that is relieved upon NPM1c mutation and cytosplasmic dislocation. This leads to the upregulation of the core transcriptional program facilitating leukemia development. This program is abrogated by I-BET therapy and by nuclear restoration of NPM1. Finally, we demonstrate the efficacy of I-BET151 in a unique murine model and in primary patient samples of NPM1c AML. Taken together, our data support the use of BET inhibitors in clinical trials in AML."><meta property="og:image" content="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/featured.png">
  <meta property="twitter:image" content="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/featured.png"><meta property="og:locale" content="en-us">
  
    
      <meta property="article:published_time" content="2014-02-01T00:00:00&#43;00:00">
    
    <meta property="article:modified_time" content="2014-02-01T00:00:00&#43;00:00">
  

  


    











<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "Article",
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/"
  },
  "headline": "Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia",
  
  "image": [
    "/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/featured.png"
  ],
  
  "datePublished": "2014-02-01T00:00:00Z",
  "dateModified": "2014-02-01T00:00:00Z",
  
  "author": {
    "@type": "Person",
    "name": "Dawson M"
  },
  
  "publisher": {
    "@type": "Organization",
    "name": "IRunFasterThanMyCode",
    "logo": {
      "@type": "ImageObject",
      "url": "/img/irunfasterthanmycode.jpg"
    }
  },
  "description": "Recent evidence suggests that inhibition of bromodomain and extra-terminal (BET) epigenetic readers may have clinical utility against acute myeloid leukemia (AML). Here we validate this hypothesis, demonstrating the efficacy of the BET inhibitor I-BET151 across a variety of AML subtypes driven by disparate mutations. We demonstrate that a common ‘core’ transcriptional program, which is HOX gene independent, is downregulated in AML and underlies sensitivity to I-BET treatment. This program is enriched for genes that contain ‘super-enhancers’, recently described regulatory elements postulated to control key oncogenic driver genes. Moreover, our program can independently classify AML patients into distinct cytogenetic and molecular subgroups, suggesting that it contains biomarkers of sensitivity and response. We focus AML with mutations of the Nucleophosmin gene (NPM1) and show evidence to suggest that wild-type NPM1 has an inhibitory influence on BRD4 that is relieved upon NPM1c mutation and cytosplasmic dislocation. This leads to the upregulation of the core transcriptional program facilitating leukemia development. This program is abrogated by I-BET therapy and by nuclear restoration of NPM1. Finally, we demonstrate the efficacy of I-BET151 in a unique murine model and in primary patient samples of NPM1c AML. Taken together, our data support the use of BET inhibitors in clinical trials in AML."
}
</script>

  

  


  


  





  <title>Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia | IRunFasterThanMyCode</title>

</head>

<body id="top" data-spy="scroll" data-offset="70" data-target="#TableOfContents" >

  <aside class="search-results" id="search">
  <div class="container">
    <section class="search-header">

      <div class="row no-gutters justify-content-between mb-3">
        <div class="col-6">
          <h1>Search</h1>
        </div>
        <div class="col-6 col-search-close">
          <a class="js-search" href="#"><i class="fas fa-times-circle text-muted" aria-hidden="true"></i></a>
        </div>
      </div>

      <div id="search-box">
        
        <input name="q" id="search-query" placeholder="Search..." autocapitalize="off"
        autocomplete="off" autocorrect="off" spellcheck="false" type="search">
        
      </div>

    </section>
    <section class="section-search-results">

      <div id="search-hits">
        
      </div>

    </section>
  </div>
</aside>


  
<nav class="navbar navbar-light fixed-top navbar-expand-lg py-0 compensate-for-scrollbar" id="navbar-main">
  <div class="container">

    
      <a class="navbar-brand" href="/"><img src="/img/irunfasterthanmycode.jpg" alt="IRunFasterThanMyCode"></a>
      
      <button type="button" class="navbar-toggler" data-toggle="collapse"
              data-target="#navbar" aria-controls="navbar" aria-expanded="false" aria-label="Toggle navigation">
        <span><i class="fas fa-bars"></i></span>
      </button>
      

    
    <div class="collapse navbar-collapse" id="navbar">

      
      
      <ul class="navbar-nav mr-auto">
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#about"><span>Home</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#posts"><span>Posts</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#projects"><span>Projects</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#featured"><span>Publications</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#resources"><span>Resources</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/resources/r-tutorial/index.html"><span>R</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/resources/python-tutorial/index.html"><span>Python</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        
          
          
          
            
          
          
        

        <li class="nav-item">
          <a class="nav-link " href="/#contact"><span>Contact</span></a>
        </li>

        
        

        

        
        
        
          
        

        
        
        
        
        
        

        <li class="nav-item">
          <a class="nav-link " href="/cv/SamRobson_CV_Academic.pdf"><span>CV</span></a>
        </li>

        
        

      
      </ul>
      <ul class="navbar-nav ml-auto">
      

        

        
        <li class="nav-item">
          <a class="nav-link js-search" href="#"><i class="fas fa-search" aria-hidden="true"></i></a>
        </li>
        

        

        
        <li class="nav-item">
          <a class="nav-link js-dark-toggle" href="#"><i class="fas fa-moon" aria-hidden="true"></i></a>
        </li>
        

      </ul>

    </div>
  </div>
</nav>


  <div class="pub">

  




















  
  
    
  


<div class="article-container pt-3">
  <h1>Recurrent mutations, including NPM1c, activate a BRD4-dependent core transcriptional program in acute myeloid leukemia</h1>

  

  



<div class="article-metadata">

  
  
  
  
  <div>
    



  
  <span><a href="/authors/dawson-m/">Dawson M</a></span>, <span><a href="/authors/gudgin-e/">Gudgin E</a></span>, <span><a href="/authors/horton-s/">Horton S</a></span>, <span><a href="/authors/giotopoulos-g/">Giotopoulos G</a></span>, <span><a href="/authors/meduri-e/">Meduri E</a></span>, <span><a href="/authors/samrobson/">Sam Robson</a></span>, <span><a href="/authors/cannizzero-e/">Cannizzero E</a></span>, <span><a href="/authors/osaki-h/">Osaki H</a></span>, <span><a href="/authors/wiese-m/">Wiese M</a></span>, <span><a href="/authors/putwain-s/">Putwain S</a></span>, <span><a href="/authors/fong-c/">Fong C</a></span>, <span><a href="/authors/grove-c/">Grove C</a></span>, <span><a href="/authors/craig-j/">Craig J</a></span>, <span><a href="/authors/dittmann-a/">Dittmann A</a></span>, <span><a href="/authors/lugo-d/">Lugo D</a></span>, <span><a href="/authors/jeffrey-p/">Jeffrey P</a></span>, <span><a href="/authors/drewes-g/">Drewes G</a></span>, <span><a href="/authors/lee-k/">Lee K</a></span>, <span><a href="/authors/bullinger-l/">Bullinger L</a></span>, <span><a href="/authors/prinjha-r/">Prinjha R</a></span>, <span><a href="/authors/kouzarides-t/">Kouzarides T</a></span>, <span><a href="/authors/vassiliou-g/">Vassiliou G</a></span>, <span><a href="/authors/huntly-p/">Huntly P</a></span>

  </div>
  
  

  
  <span class="article-date">
    
    
      
    
    February 2014
  </span>
  

  

  

  
  
  
  <span class="middot-divider"></span>
  <a href="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/#disqus_thread"></a>
  

  
  

  
    
<div class="share-box" aria-hidden="true">
  <ul class="share">
    
      
      
      
        
      
      
      
      <li>
        <a href="https://twitter.com/intent/tweet?url=/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/&amp;text=Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia" target="_blank" rel="noopener" class="share-btn-twitter">
          <i class="fab fa-twitter"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.facebook.com/sharer.php?u=/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/&amp;t=Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia" target="_blank" rel="noopener" class="share-btn-facebook">
          <i class="fab fa-facebook-f"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="mailto:?subject=Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia&amp;body=/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/" target="_blank" rel="noopener" class="share-btn-email">
          <i class="fas fa-envelope"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://www.linkedin.com/shareArticle?url=/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/&amp;title=Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia" target="_blank" rel="noopener" class="share-btn-linkedin">
          <i class="fab fa-linkedin-in"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://web.whatsapp.com/send?text=Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia%20/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/" target="_blank" rel="noopener" class="share-btn-whatsapp">
          <i class="fab fa-whatsapp"></i>
        </a>
      </li>
    
      
      
      
        
      
      
      
      <li>
        <a href="https://service.weibo.com/share/share.php?url=/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/&amp;title=Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia" target="_blank" rel="noopener" class="share-btn-weibo">
          <i class="fab fa-weibo"></i>
        </a>
      </li>
    
  </ul>
</div>


  

</div>

  













<div class="btn-links mb-3">
  
  








  
    
  



<a class="btn btn-outline-primary my-1 mr-1" href="/pdf/mypapers/2014_Dawson_Recurrent%20mutations,%20including%20NPM1c,%20activate%20a%20BRD4-dependent%20core%20transcriptional%20program%20in%20acute%20myeloid%20leukemia.pdf" target="_blank" rel="noopener">
  PDF
</a>

















</div>


</div>


<div class="article-header article-container featured-image-wrapper mt-4 mb-4" style="max-width: 720px; max-height: 196px;">
  <div style="position: relative">
    <img src="/publication/2014_recurrent_mutations_including_nmp1c_activates_a_brd4_dependent_core_transcriptional_program_in_acute_myeloid_leukemia/featured_hu32bac7eed65f0bc4bc21c1a8216971fa_1198433_720x0_resize_lanczos_2.png" alt="" class="featured-image">
    
  </div>
</div>



  <div class="article-container">

    
    <h3>Abstract</h3>
    <p class="pub-abstract">Recent evidence suggests that inhibition of bromodomain and extra-terminal (BET) epigenetic readers may have clinical utility against acute myeloid leukemia (AML). Here we validate this hypothesis, demonstrating the efficacy of the BET inhibitor I-BET151 across a variety of AML subtypes driven by disparate mutations. We demonstrate that a common ‘core’ transcriptional program, which is HOX gene independent, is downregulated in AML and underlies sensitivity to I-BET treatment. This program is enriched for genes that contain ‘super-enhancers’, recently described regulatory elements postulated to control key oncogenic driver genes. Moreover, our program can independently classify AML patients into distinct cytogenetic and molecular subgroups, suggesting that it contains biomarkers of sensitivity and response. We focus AML with mutations of the Nucleophosmin gene (NPM1) and show evidence to suggest that wild-type NPM1 has an inhibitory influence on BRD4 that is relieved upon NPM1c mutation and cytosplasmic dislocation. This leads to the upregulation of the core transcriptional program facilitating leukemia development. This program is abrogated by I-BET therapy and by nuclear restoration of NPM1. Finally, we demonstrate the efficacy of I-BET151 in a unique murine model and in primary patient samples of NPM1c AML. Taken together, our data support the use of BET inhibitors in clinical trials in AML.</p>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Type</div>
          <div class="col-12 col-md-9">
            
            
            <a href="/publication/#2">
              Journal article
            </a>
            
          </div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    
    <div class="row">
      <div class="col-md-1"></div>
      <div class="col-md-10">
        <div class="row">
          <div class="col-12 col-md-3 pub-row-heading">Publication</div>
          <div class="col-12 col-md-9">Leukemia. 2014 Feb;28(2):311-20</div>
        </div>
      </div>
      <div class="col-md-1"></div>
    </div>
    <div class="d-md-none space-below"></div>
    

    <div class="space-below"></div>

    <div class="article-style"></div>

    

<div class="article-tags">
  
  <a class="badge badge-light" href=""></a>
  
</div>


    








  
  
    
  
  






  
  
  
  
  <div class="media author-card">
    

    <div class="media-body">
      <h5 class="card-title"><a href="/authors/dawson-m/"></a></h5>
      
      
      <ul class="network-icon" aria-hidden="true">
  
</ul>

    </div>
  </div>




    
<section id="comments">
  
    
<div id="disqus_thread"></div>
<script>
  let disqus_config = function () {
    
    
    
  };
  (function() {
    if (["localhost", "127.0.0.1"].indexOf(window.location.hostname) != -1) {
      document.getElementById('disqus_thread').innerHTML = 'Disqus comments not available by default when the website is previewed locally.';
      return;
    }
    var d = document, s = d.createElement('script'); s.async = true;
    s.src = 'https://' + "https-irunfasterthanmycode-github-io" + '.disqus.com/embed.js';
    s.setAttribute('data-timestamp', +new Date());
    (d.head || d.body).appendChild(s);
  })();
</script>
<noscript>Please enable JavaScript to view the <a href="https://disqus.com/?ref_noscript">comments powered by Disqus.</a></noscript>
<a href="https://disqus.com" class="dsq-brlink">comments powered by <span class="logo-disqus">Disqus</span></a>


  
</section>



  </div>
</div>



      

    
    
    
    <script src="/js/mathjax-config.js"></script>
    

    
    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery/3.4.1/jquery.min.js" integrity="sha256-CSXorXvZcTkaix6Yvo6HppcZGetbYMGWSFlBw8HfCJo=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.4/imagesloaded.pkgd.min.js" integrity="sha256-lqvxZrPLtfffUl2G/e7szqSvPBILGbwmsGE1MKlOi0Q=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/jquery.isotope/3.0.6/isotope.pkgd.min.js" integrity="sha256-CBrpuqrMhXwcLLUd5tvQ4euBHCdh7wGlDfNz8vbu/iI=" crossorigin="anonymous"></script>
      <script src="https://cdnjs.cloudflare.com/ajax/libs/fancybox/3.2.5/jquery.fancybox.min.js" integrity="sha256-X5PoE3KU5l+JcX+w09p/wHl9AzK333C4hJ2I9S5mD4M=" crossorigin="anonymous"></script>

      

      
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/highlight.min.js" integrity="sha256-aYTdUrn6Ow1DDgh5JTc3aDGnnju48y/1c8s1dgkYPQ8=" crossorigin="anonymous"></script>
        
        <script src="https://cdnjs.cloudflare.com/ajax/libs/highlight.js/9.15.6/languages/r.min.js"></script>
        
      

      
      
      <script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.4/MathJax.js?config=TeX-AMS_CHTML-full" integrity="sha256-GhM+5JHb6QUzOQPXSJLEWP7R73CbkisjzK5Eyij4U9w=" crossorigin="anonymous" async></script>
      
    

    
    
      <script src="https://cdnjs.cloudflare.com/ajax/libs/leaflet/1.2.0/leaflet.js" integrity="sha512-lInM/apFSqyy1o6s89K4iQUKg6ppXEgsVxT35HbzUupEVRh2Eu9Wdl4tHj7dZO0s1uvplcYGmt3498TtHq+log==" crossorigin="anonymous"></script>
    

    
    
    <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    
    
    
    
    <script>
      const search_config = {"indexURI":"/index.json","minLength":1,"threshold":0.3};
      const i18n = {"no_results":"No results found","placeholder":"Search...","results":"results found"};
      const content_type = {
        'post': "Posts",
        'project': "Projects",
        'publication' : "Publications",
        'talk' : "Talks"
        };
    </script>
    

    
    

    
    
    <script id="search-hit-fuse-template" type="text/x-template">
      <div class="search-hit" id="summary-{{key}}">
      <div class="search-hit-content">
        <div class="search-hit-name">
          <a href="{{relpermalink}}">{{title}}</a>
          <div class="article-metadata search-hit-type">{{type}}</div>
          <p class="search-hit-description">{{snippet}}</p>
        </div>
      </div>
      </div>
    </script>
    

    
    
    <script src="https://cdnjs.cloudflare.com/ajax/libs/fuse.js/3.2.1/fuse.min.js" integrity="sha256-VzgmKYmhsGNNN4Ph1kMW+BjoYJM2jV5i4IlFoeZA9XI=" crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/mark.js/8.11.1/jquery.mark.min.js" integrity="sha256-4HLtjeVgH0eIB3aZ9mLYF6E8oU5chNdjU6p6rrXpl9U=" crossorigin="anonymous"></script>
    

    
    

    
    
    <script id="dsq-count-scr" src="https://https-irunfasterthanmycode-github-io.disqus.com/count.js" async></script>
    

    
    
    
    
    
    
    
    
    
      
    
    
    
    
    <script src="/js/academic.min.d6bd04fdad2ad213aa8111c5a3b72fc5.js"></script>

    






  
  <div class="container">
    <footer class="site-footer">
  

  <p class="powered-by">
    &copy; 2017 Sam Robson &middot; 

    Powered by the
    <a href="https://sourcethemes.com/academic/" target="_blank" rel="noopener">Academic theme</a> for
    <a href="https://gohugo.io" target="_blank" rel="noopener">Hugo</a>.

    
    <span class="float-right" aria-hidden="true">
      <a href="#" class="back-to-top">
        <span class="button_icon">
          <i class="fas fa-chevron-up fa-2x"></i>
        </span>
      </a>
    </span>
    
  </p>
</footer>

  </div>
  

  
<div id="modal" class="modal fade" role="dialog">
  <div class="modal-dialog">
    <div class="modal-content">
      <div class="modal-header">
        <h5 class="modal-title">Cite</h5>
        <button type="button" class="close" data-dismiss="modal" aria-label="Close">
          <span aria-hidden="true">&times;</span>
        </button>
      </div>
      <div class="modal-body">
        <pre><code class="tex hljs"></code></pre>
      </div>
      <div class="modal-footer">
        <a class="btn btn-outline-primary my-1 js-copy-cite" href="#" target="_blank">
          <i class="fas fa-copy"></i> Copy
        </a>
        <a class="btn btn-outline-primary my-1 js-download-cite" href="#" target="_blank">
          <i class="fas fa-download"></i> Download
        </a>
        <div id="modal-error"></div>
      </div>
    </div>
  </div>
</div>

</body>
</html>
